245 related articles for article (PubMed ID: 19010684)
1. Synthesis and in vitro activities of a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via an octadecylglycerol residue.
Schott H; Hamprecht K; Schott S; Schott TC; Schwendener RA
Bioorg Med Chem; 2009 Jan; 17(1):303-10. PubMed ID: 19010684
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY
J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355
[TBL] [Abstract][Full Text] [Related]
3. Effect of (r)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (H2G) and AZT-lipid-PFA on human herpesvirus-6B infected cells.
Yao K; Hoest C; Rashti F; Schott TC; Jacobson S
J Clin Virol; 2009 Sep; 46(1):10-4. PubMed ID: 19524486
[TBL] [Abstract][Full Text] [Related]
4. In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudine.
Hostetler KY; Hammond JL; Kini GD; Hostetler SE; Beadle JR; Aldern KA; Chou TC; Richman DD; Mellors JW
Antivir Chem Chemother; 2000 May; 11(3):213-9. PubMed ID: 10901292
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal toxicology in rabbits of two preparations of 1-O-octadecyl-sn-glycerol-3-phosphonoformate, a sustained-delivery anti-CMV drug.
Cheng L; Hostetler KY; Gardner MF; Avila CP; Bergeron-Lynn G; Keefe KS; Wiley CA; Freeman WR
Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1487-95. PubMed ID: 10359331
[TBL] [Abstract][Full Text] [Related]
6. Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistance.
Hammond JL; Koontz DL; Bazmi HZ; Beadle JR; Hostetler SE; Kini GD; Aldern KA; Richman DD; Hostetler KY; Mellors JW
Antimicrob Agents Chemother; 2001 Jun; 45(6):1621-8. PubMed ID: 11353603
[TBL] [Abstract][Full Text] [Related]
7. Alkylthioglycerol prodrugs of foscarnet: synthesis, oral bioavailability and structure-activity studies in human cytomegalovirus-, herpes simplex virus type 1- and human immunodeficiency virus type 1-infected cells.
Beadle JR; Kini GD; Aldern KA; Gardner MF; Wright KN; Richman DD; Hostetler KY
Antivir Chem Chemother; 1998 Jan; 9(1):33-40. PubMed ID: 9875375
[TBL] [Abstract][Full Text] [Related]
8. Lipid prodrugs of phosphonoacids: greatly enhanced antiviral activity of 1-O-octadecyl-sn-glycero-3-phosphonoformate in HIV-1, HSV-1 and HCMV-infected cells, in vitro.
Hostetler KY; Kini GD; Beadle JR; Aldern KA; Gardner MF; Border R; Kumar R; Barshak L; Sridhar CN; Wheeler CJ; Richman DD
Antiviral Res; 1996 Jun; 31(1-2):59-67. PubMed ID: 8793009
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiviral evaluation of SATE-foscarnet prodrugs and new foscarnet-AZT conjugates.
Meier C; Aubertin AM; de Monte M; Faraj A; Sommadossi JP; Périgaud C; Imbach JL; Gosselin G
Antivir Chem Chemother; 1998 Jan; 9(1):41-52. PubMed ID: 9875376
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of ganciclovir elaidic acid ester against herpesviruses.
Andrei G; Snoeck R; Neyts J; Sandvold ML; Myhren F; De Clercq E
Antiviral Res; 2000 Mar; 45(3):157-67. PubMed ID: 10771080
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiviral activity of 1-O-octadecyl-2-O-alkyl-sn-glycero-3-foscarnet conjugates in human cytomegalovirus-infected cells.
Kini GD; Hostetler SE; Beadle JR; Aldern KA
Antiviral Res; 1997 Nov; 36(2):115-24. PubMed ID: 9443668
[TBL] [Abstract][Full Text] [Related]
12. Alkoxy propane prodrugs of foscarnet: effect of alkyl chain length on in vitro antiviral activity in cells infected with HIV-1, HSV-1 and HCMV.
Kini GD; Beadle JR; Xie H; Aldern KA; Richman DD; Hostetler KY
Antiviral Res; 1997 Sep; 36(1):43-53. PubMed ID: 9330760
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal pharmacokinetics in rabbits of the foscarnet lipid prodrug: 1-O-octadecyl-sn-glycerol-3-phosphonoformate (ODG-PFA).
Cheng L; Hostetler KY; Gardner MF; Avila CP; Bergeron-Lynn G; Severson GM; Freeman WR
Curr Eye Res; 1999 Mar; 18(3):161-7. PubMed ID: 10342370
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal toxicology and therapeutic efficacy of the carboxymethyl ester of the 1-O-octadecyl-sn-glycerol-3-phosphonoformate (ODG-PFA-O-Me), a novel lipid antiviral prodrug for intraocular drug delivery.
Cheng L; Hostetler KY; Gardner MF; Avila CP; Bergeron-Lynn G; Keefe KS; Beadle JR; Wiley CA; Freeman WR
J Ocul Pharmacol Ther; 1999 Aug; 15(4):363-77. PubMed ID: 10463875
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro evaluation of S-acyl-3-thiopropyl prodrugs of Foscarnet.
Gagnard V; Leydet A; Morère A; Montero JL; Lefèbvre I; Gosselin G; Pannecouque C; De Clercq E
Bioorg Med Chem; 2004 Mar; 12(6):1393-402. PubMed ID: 15018912
[TBL] [Abstract][Full Text] [Related]
16. Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet.
Tachedjian G; Mellors J; Bazmi H; Birch C; Mills J
J Virol; 1996 Oct; 70(10):7171-81. PubMed ID: 8794364
[TBL] [Abstract][Full Text] [Related]
17. In vivo toxicity of foscarnet and zidovudine given alone or in combination.
Omar RF; Gourde P; Désormeaux A; Tremblay M; Beauchamp D; Bergeron MG
Toxicol Appl Pharmacol; 1996 Aug; 139(2):324-32. PubMed ID: 8806849
[TBL] [Abstract][Full Text] [Related]
18. [Development of resistance of herpes simplex virus to antivirus drugs in vitro].
Chen ZJ; Liu WG; Song JZ
Yao Xue Xue Bao; 1992; 27(1):10-4. PubMed ID: 1382356
[TBL] [Abstract][Full Text] [Related]
19. In vitro anti-hepatitis B virus activities of 5"-O-myristoyl analogue derivatives of 3"-fluoro-2",3"-dideoxythymidine (FLT) and 3"-azido-2",3"-dideoxythymidine (AZT).
Parang K; Wiebe LI; Knaus EE; Huang JS; Tyrrell DL
J Pharm Pharm Sci; 1998; 1(3):108-14. PubMed ID: 10948398
[TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
Kong XB; Zhu QY; Ruprecht RM; Watanabe KA; Zeidler JM; Gold JW; Polsky B; Armstrong D; Chou TC
Antimicrob Agents Chemother; 1991 Oct; 35(10):2003-11. PubMed ID: 1722077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
